Haiyi Liu

机构：Tianjin University of Science and Technology, Guizhou University, Nankai University, Tianjin International Joint Academy of Biomedicine, Tianjin Medical University Eye Hospital, Guizhou Institute of Technology, Tianjin Medical University · ORCID：0000-0003-4289-8480

发表论文 107 篇 · 总被引 1976 次 · h-index 19

代表论文

• Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study (2025 · Cancer Cell · 被引 23)
• SLC14A1 and TGF-β signaling: a feedback loop driving EMT and colorectal cancer metachronous liver metastasis (2024 · Journal of Experimental & Clinical Cancer Research · 被引 19)
• Neoadjuvant treatment of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody) in patients with microsatellite instability-high/mismatch repair-deficient colorectal cancer: Results from a randomized, open-labeled, phase Ib study. (2024 · Journal of Clinical Oncology · 被引 19)
• Gas and Droplet Dynamics for Filament-Assisted Free-Space Optical Communication through Clouds (2024 · Ultrafast Science · 被引 11)
• Lymph nodes molecular subtypes unravel lymph nodes heterogeneity and clinical implications in colorectal cancer (2025 · Nature Communications · 被引 9)
• Impact of lymph node metastasis on immune microenvironment and prognosis in colorectal cancer liver metastasis: insights from multiomics profiling (2025 · British Journal of Cancer · 被引 7)